RCT targeting noradrenergic stress mechanisms in alcoholism with doxazosin.
National Institute of Alcohol Abuse and Alcoholism (R01 AA024388)
John Curtin (PI), Craig Berridge (Co-I), Aleksandra Zgierska (Co-I)
Direct Costs: $1,420,889
Status: Funded. 09/01/2015 – 05/31/2020
Dynamic, real-time prediction of alcohol use lapse using mHealth technologies.
National Institute of Alcohol Abuse and Alcoholism (R01 AA024391)
John Curtin (PI), Xiaojin Zhu (Co-I), Oguzhan Alagoz (Co-I), David Gustafson (Co-I)
Direct Costs: $1,237,770
Status: Funded. 08/10/2015 – 05/31/2020
Repurposing alpha1 noradrenergic antagonists for alcoholism treatment.
National Institute on Alcohol Abuse and Alcoholism, National Research Service Award (F31 AA022845)
Jesse Kaye (Trainee), John Curtin (Sponsor), Craig Berridge (Co-Sponsor).
Direct costs: $93,075
Status: Funded. 09/2014 – 08/2017
Clinical relevance of stress neuroadaptation in tobacco dependence.
National Institute on Drug Abuse (R01 DA033809)
John Curtin (PI), Timothy Baker (Co-I), Megan Piper (Co-I), Daniel Bolt (Co-I)
Direct costs: $1,508,145
Status: Funded. 08/2012 – 06/2017
Noradrenergic stress mechanisms in alcoholism: Preclinical translation and drug repurposing.
University of Wisconsin, Office of the Vice Chancellor for Research and Graduate Education
John Curtin (PI)
Direct costs: $36,097
Status: Funded. 07/2015 - 06/2016
Page last updated: 2/13/2017